Anti-VEGF Injection (Lucentis / Avastin / Eylea)

What Is The Cost Of Anti-VEGF Injection (Lucentis / Avastin / Eylea) In India?

The cost of Anti-VEGF injections in India typically ranges from Rs 5,000 to Rs 1,20,000 per injection, depending on the medication used, the retinal condition being treated, hospital infrastructure, diagnostic imaging requirements, and the number of injections needed. Costs may be higher for premium medications, advanced retinal evaluations, or long-term treatment plans requiring repeated injections. The table below provides approximate cost ranges for Anti-VEGF treatment in India.

The actual cost may vary based on the patient’s eye condition, frequency of injections, retinal scans such as OCT or fluorescein angiography, specialist consultation, and hospital protocols.

Enquire now

Factors Influencing the Cost Of Anti-VEGF Injection (Lucentis / Avastin / Eylea):

The cost of Anti-VEGF injections can vary depending on several medical and treatment-related factors, including:

• Type of Anti-VEGF Medication: The cost differs significantly between Avastin, Lucentis, and Eylea based on brand, formulation, and availability.
• Underlying Eye Condition: Treatment costs may vary depending on whether the injection is for diabetic macular edema, wet AMD, retinal vein occlusion, or other retinal disorders.
• Number of Injections Required: Some conditions require a single injection, while others need multiple injections over months or years, increasing the overall cost.
• Diagnostic Retinal Imaging: Tests such as OCT, fluorescein angiography, or retinal scans performed before and during treatment can add to the total expense.
• Hospital Infrastructure & Facilities: Costs may vary depending on the hospital’s technology, sterile injection setup, and overall clinical facilities.
• Retina Specialist Expertise: Consultation and treatment charges may differ based on the experience and expertise of the retinal specialist.
• Treatment Protocol: Loading doses, maintenance therapy, or personalised treatment schedules can influence the overall cost.
• Management of Associated Eye Conditions: Additional treatment for cataract, glaucoma, or retinal complications may increase expenses.
• Follow-up Visits: Regular monitoring after the injection to assess treatment response can contribute to the total treatment cost.
• Geographic Location: Treatment costs may vary between cities, hospitals, and regions across India.

Enquire now

Types of Anti-VEGF Injection (Lucentis / Avastin / Eylea):

Anti-VEGF injections are classified based on the medication used to block abnormal blood vessel growth and fluid leakage in retinal diseases. Common types include:

• Avastin (Bevacizumab): A widely used Anti-VEGF injection that helps reduce abnormal blood vessel growth and retinal swelling. It is often chosen as a cost-effective treatment option for conditions such as wet age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO).
• Lucentis (Ranibizumab): A specifically designed Anti-VEGF medication for eye conditions that works by blocking VEGF activity inside the retina. It is commonly used for wet AMD, DME, RVO, and other retinal vascular disorders, offering effective vision preservation and improvement.
• Eylea (Aflibercept): An advanced Anti-VEGF injection that blocks VEGF and related growth factors, helping control retinal swelling and abnormal vessel formation. It is often preferred for certain retinal diseases requiring longer treatment intervals in some patients.
• Biosimilar Anti-VEGF Injections: Newer biosimilar versions of Anti-VEGF medications may be available in some settings, offering similar effectiveness with potentially lower treatment costs, depending on approval and availability.
• Anti-VEGF for Diabetic Macular Edema (DME): Anti-VEGF injections help treat Diabetic Macular Edema (DME) by reducing fluid leakage and swelling in the retina, helping preserve or improve vision. Common options include Avastin, Lucentis, and Eylea, with treatment usually requiring multiple outpatient injections and regular retinal monitoring.
• Anti-VEGF for Wet Age-Related Macular Degeneration (AMD): Anti-VEGF injections are a standard treatment for wet Age-Related Macular Degeneration (AMD), helping block abnormal blood vessel growth and leakage beneath the retina that can cause rapid vision loss. Common options include Avastin, Lucentis, and Eylea, with treatment typically given as repeated outpatient injections along with regular retinal monitoring to preserve or improve vision.
• Anti-VEGF for Retinal Vein Occlusion (RVO): Anti-VEGF injections are used to treat Retinal Vein Occlusion (RVO) by reducing retinal swelling and controlling abnormal blood vessel leakage caused by blocked retinal veins. Common treatment options include Avastin, Lucentis, and Eylea, usually given as outpatient injections with regular follow-up scans to help stabilise or improve vision.
• Anti-VEGF for Myopic Choroidal Neovascularisation (Myopic CNV): Anti-VEGF injections are used to treat Myopic Choroidal Neovascularisation (Myopic CNV) by blocking abnormal blood vessel growth beneath the retina caused by high myopia. Common options include Avastin, Lucentis, and Eylea, administered as outpatient injections with regular retinal monitoring to prevent vision loss and improve visual outcomes.
• Anti-VEGF with Retinal Imaging & Evaluation: Anti-VEGF treatment is often combined with retinal imaging and evaluation to accurately diagnose the condition, assess retinal swelling, and monitor treatment response. Tests such as OCT, fluorescein angiography, and retinal examination help guide the choice and timing of Anti-VEGF injections for better visual outcomes.

Enquire now

Making an Informed Decision on Anti-VEGF Injection (Lucentis / Avastin / Eylea) In India

Selecting Anti-VEGF injection treatment is an important step in managing retinal diseases and preserving vision. It is always advisable to consult an experienced retina specialist before starting treatment. Understanding why Anti-VEGF therapy is recommended, the eye condition being treated, expected benefits, possible side effects, and the number of injections required helps patients make a well-informed decision. Patients should also choose a trusted hospital with advanced ophthalmology infrastructure, modern retinal imaging facilities, and experienced eye specialists. Comparing treatment quality, safety standards, clinical expertise, and follow-up care is more important than focusing only on cost. Early and appropriate treatment can help prevent vision loss and improve long-term visual outcomes.

Enquire now